Paris - Delayed Quote EUR
DBV Technologies S.A. (DBV.PA)
1.6700
+0.0420
+(2.58%)
At close: 5:36:19 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 556.06k | 559.15k | 2.38M | 2.38M |
Low Estimate | 441k | 441k | 2.03M | 1.76M |
High Estimate | 671.13k | 677.3k | 2.72M | 3M |
Year Ago Sales | 1.07M | 1.02M | 3.88M | 2.38M |
Sales Growth (year/est) | -48.26% | -45.45% | -38.80% | 0.18% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
DBV.PA | -- | -- | -- | -- |
S&P 500 | 12.65% | 2.48% | 7.35% | 14.09% |
Related Tickers
POXEL.PA Poxel S.A.
0.4725
-7.17%
GNFT.PA Genfit S.A.
3.8560
-0.31%
VLA.PA Valneva SE
2.8400
-0.98%
ALCLS.PA Cellectis S.A.
1.3860
-0.72%
OSE.PA OSE Immunotherapeutics SA
5.94
-3.96%
PHXM.PA PHAXIAM Therapeutics S.A.
0.2000
-2.91%
IPH.PA Innate Pharma S.A.
1.9200
-2.24%
ALBPS.PA Biophytis S.A.
0.1444
+0.28%
SIGHT.PA GenSight Biologics S.A.
0.2100
-19.23%
TNG.PA Transgene SA
0.6600
-4.07%